SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ZOL'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQJ_A_RISA901_1 (GERANYLTRANSTRANSFER ASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.33A	1rqjA-4p0vA: 31.1	1rqjA-4p0vA: 27.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQJ_B_RISB903_1 (GERANYLTRANSTRANSFER ASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.34A	1rqjB-4p0vA: 31.2	1rqjB-4p0vA: 27.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YHL_A_RISA1400_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.30A	1yhlA-4p0vA: 45.8	1yhlA-4p0vA: 37.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YQ7_A_RISA901_1 (FARNESYL PYROPHOSPHATE SYNTHETASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.34A	1yq7A-4p0vA: 53.1	1yq7A-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YV5_A_RISA901_1 (FARNESYL PYROPHOSPHATE SYNTHETASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 10	ASP A 107 ARG A 112 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	1.20A	1yv5A-4p0vA: 53.5	1yv5A-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YV5_A_RISA901_1 (FARNESYL PYROPHOSPHATE SYNTHETASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.18A	1yv5A-4p0vA: 53.5	1yv5A-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ZW5_A_ZOLA901_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.27A	1zw5A-4p0vA: 54.8	1zw5A-4p0vA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2E91_A_ZOLA901_1 (GERANYLGERANYL PYROPHOSPHATE SYNTHETASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	8 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A)	0.41A	2e91A-4p0vA: 25.3	2e91A-4p0vA: 24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2E91_B_ZOLB902_1 (GERANYLGERANYL PYROPHOSPHATE SYNTHETASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	8 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A)	0.56A	2e91B-4p0vA: 24.4	2e91B-4p0vA: 24.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F89_F_210F9001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.27A	2f89F-4p0vA: 56.6	2f89F-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.13A	2f8cF-4p0vA: 56.3	2f8cF-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8Z_F_ZOLF5001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 10	ASP A 107 ARG A 112 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	1.16A	2f8zF-4p0vA: 56.6	2f8zF-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8Z_F_ZOLF5001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.29A	2f8zF-4p0vA: 56.6	2f8zF-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F94_F_BFQF9001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 12	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.56A	2f94F-4p0vA: 55.2	2f94F-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F94_F_BFQF9001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 12	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.27A	2f94F-4p0vA: 55.2	2f94F-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F9K_F_ZOLF9001_1 (FARNESYL DIPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.18A	2f9kF-4p0vA: 55.3	2f9kF-4p0vA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2O1O_A_RISA400_1 (PUTATIVE FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	8 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A)	0.40A	2o1oA-4p0vA: 36.3	2o1oA-4p0vA: 29.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2O1O_B_RISB400_1 (PUTATIVE FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	8 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A)	0.43A	2o1oB-4p0vA: 37.0	2o1oB-4p0vA: 29.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2O1O_B_RISB400_1 (PUTATIVE FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 10	LEU A 100 ASP A 103 ASP A 107 GLN A 171 LYS A 200 LYS A 266	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) MG A 405 ( 4.4A)	1.20A	2o1oB-4p0vA: 37.0	2o1oB-4p0vA: 29.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q58_A_ZOLA1_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 10	LEU A 100 ASP A 103 ARG A 112 GLN A 171 LYS A 200 ASP A 261	None MG A 405 (-2.5A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) MG A 404 ( 3.7A)	1.35A	2q58A-4p0vA: 36.2	2q58A-4p0vA: 29.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q58_A_ZOLA1_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 244	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) None	0.60A	2q58A-4p0vA: 36.2	2q58A-4p0vA: 29.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q58_B_ZOLB2_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	7 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A)	0.42A	2q58B-4p0vA: 36.3	2q58B-4p0vA: 29.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q58_B_ZOLB2_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 9	ASP A 103 ASP A 107 GLN A 171 LYS A 200 LYS A 266	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) MG A 405 ( 4.4A)	1.38A	2q58B-4p0vA: 36.3	2q58B-4p0vA: 29.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QIS_A_RISA901_1 (FARNESYL PYROPHOSPHATE SYNTHETASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.23A	2qisA-4p0vA: 54.7	2qisA-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EZ3_A_ZOLA397_1 (FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.48A	3ez3A-4p0vA: 45.5	3ez3A-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EZ3_B_ZOLB397_1 (FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.32A	3ez3B-4p0vA: 44.7	3ez3B-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EZ3_C_ZOLC397_1 (FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.46A	3ez3C-4p0vA: 45.4	3ez3C-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EZ3_D_ZOLD397_1 (FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.30A	3ez3D-4p0vA: 44.3	3ez3D-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IBA_A_ZOLA901_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.45A	3ibaA-4p0vA: 45.6	3ibaA-4p0vA: 37.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LDW_A_ZOLA397_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.48A	3ldwA-4p0vA: 45.4	3ldwA-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LDW_B_ZOLB397_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.32A	3ldwB-4p0vA: 44.6	3ldwB-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LDW_C_ZOLC397_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.45A	3ldwC-4p0vA: 45.3	3ldwC-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LDW_D_ZOLD397_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.31A	3ldwD-4p0vA: 44.3	3ldwD-4p0vA: 32.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N45_F_ZOLF354_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.19A	3n45F-4p0vA: 54.9	3n45F-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N46_F_ZOLF354_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.25A	3n46F-4p0vA: 54.3	3n46F-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KFA_A_ZOLA404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.30A	4kfaA-4p0vA: 53.4	4kfaA-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KPD_A_RISA405_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.21A	4kpdA-4p0vA: 55.9	4kpdA-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KPJ_A_210A901_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.26A	4kpjA-4p0vA: 53.7	4kpjA-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KQ5_A_ZOLA404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.31A	4kq5A-4p0vA: 54.2	4kq5A-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KQS_A_RISA405_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.22A	4kqsA-4p0vA: 54.8	4kqsA-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N9U_A_RISA404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 GLN A 171 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 ( 3.8A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.29A	4n9uA-4p0vA: 54.2	4n9uA-4p0vA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NG6_A_RISA405_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 12	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 GLN A 171 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 ( 3.8A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.53A	4ng6A-4p0vA: 55.0	4ng6A-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NG6_A_RISA405_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 12	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.33A	4ng6A-4p0vA: 55.0	4ng6A-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NKE_A_RISA404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.38A	4nkeA-4p0vA: 53.7	4nkeA-4p0vA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NKF_A_210A404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.30A	4nkfA-4p0vA: 54.6	4nkfA-4p0vA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NUA_A_RISA901_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.44A	4nuaA-4p0vA: 54.5	4nuaA-4p0vA: 99.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGU_A_210A405_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	9 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.21A	4oguA-4p0vA: 54.2	4oguA-4p0vA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P0W_A_ZOLA501_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	11 / 11	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.14A	4p0wA-4p0vA: 57.2	4p0wA-4p0vA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q23_A_RISA901_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.21A	4q23A-4p0vA: 53.7	4q23A-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RXD_A_RISA1404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.26A	4rxdA-4p0vA: 44.9	4rxdA-4p0vA: 37.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RXD_B_RISB1504_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.25A	4rxdB-4p0vA: 45.3	4rxdB-4p0vA: 37.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RXD_C_RISC1600_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	10 / 10	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.26A	4rxdC-4p0vA: 45.2	4rxdC-4p0vA: 37.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UMJ_A_BFQA1297_1 (GERANYLTRANSTRANSFER ASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 8	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A)	0.68A	4umjA-4p0vA: 23.8	4umjA-4p0vA: 28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UMJ_B_BFQB1294_1 (GERANYLTRANSTRANSFER ASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	7 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 THR A 201	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A)	0.59A	4umjB-4p0vA: 23.8	4umjB-4p0vA: 28.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UMJ_B_BFQB1294_1 (GERANYLTRANSTRANSFER ASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None	1.24A	4umjB-4p0vA: 23.8	4umjB-4p0vA: 28.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CG5_A_RISA400_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	12 / 12	LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 GLN A 171 LYS A 200 THR A 201 TYR A 204 GLN A 240 ASP A 243 LYS A 257	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) None ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.23A	5cg5A-4p0vA: 53.8	5cg5A-4p0vA: 99.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CG6_A_RISA404_1 (FARNESYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	12 / 12	PHE A 99 LEU A 100 ASP A 103 ASP A 107 ARG A 112 THR A 167 GLN A 171 LYS A 200 THR A 201 GLN A 240 ASP A 243 LYS A 257	None None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) None ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) 1WO A 402 ( 2.8A)	0.23A	5cg6A-4p0vA: 54.7	5cg6A-4p0vA: 99.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_A_210A804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 9	LEU A 100 ASP A 103 ARG A 112 LYS A 200 LYS A 257	None MG A 405 (-2.5A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) 1WO A 402 ( 2.8A)	1.36A	5eroA-4p0vA: 27.5	5eroA-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_A_210A804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	7 / 9	LEU A 100 ASP A 103 ASP A 107 ARG A 112 LYS A 200 GLN A 240 ASP A 243	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A)	0.62A	5eroA-4p0vA: 27.5	5eroA-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_B_210B804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 9	ASP A 103 ARG A 112 LYS A 200 ASP A 244 LYS A 257	MG A 405 (-2.5A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) None 1WO A 402 ( 2.8A)	1.30A	5eroB-4p0vA: 27.1	5eroB-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_B_210B804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	7 / 9	ASP A 103 ASP A 107 ARG A 112 LYS A 200 GLN A 240 ASP A 243 ASP A 244	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) None	0.53A	5eroB-4p0vA: 27.1	5eroB-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_B_210B804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 9	ASP A 103 ASP A 107 LYS A 200 GLN A 240 ASP A 243	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A)	1.42A	5eroB-4p0vA: 27.1	5eroB-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_B_210B804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 9	ASP A 107 ARG A 112 GLN A 240 ASP A 243 ASP A 244	MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) None	1.34A	5eroB-4p0vA: 27.1	5eroB-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_C_210C804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	8 / 10	ASP A 103 ASP A 104 ASP A 107 ARG A 112 LYS A 200 GLN A 240 ASP A 243 ASP A 244	MG A 405 (-2.5A) None MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) None	0.58A	5eroC-4p0vA: 27.3	5eroC-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_C_210C804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	7 / 10	ASP A 103 ASP A 107 ARG A 112 LYS A 200 GLN A 240 ASP A 244 LYS A 257	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) None 1WO A 402 ( 2.8A)	0.98A	5eroC-4p0vA: 27.3	5eroC-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_C_210C804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 10	ASP A 103 ASP A 107 LYS A 200 GLN A 240 ASP A 243	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A)	1.39A	5eroC-4p0vA: 27.3	5eroC-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERO_C_210C804_1 (FUSICOCCADIENE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 10	ASP A 107 ASP A 104 ARG A 112 GLN A 240 ASP A 243 ASP A 244	MG A 405 (-2.4A) None ZOL A 401 ( 2.7A) ZOL A 401 (-3.5A) MG A 404 (-2.8A) None	1.37A	5eroC-4p0vA: 27.3	5eroC-4p0vA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_A_ZOLA401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 7	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A)	1.07A	6g31A-4p0vA: 26.2	6g31A-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_B_ZOLB401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 6	ASP A 103 ASP A 107 ARG A 112 GLN A 171 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A)	0.73A	6g31B-4p0vA: 26.2	6g31B-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_C_ZOLC401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 5	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A)	1.21A	6g31C-4p0vA: 26.5	6g31C-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_D_ZOLD401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 7	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171 GLN A 240	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A)	0.54A	6g31D-4p0vA: 25.4	6g31D-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_E_ZOLE401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	4 / 4	LEU A 100 ASP A 103 ASP A 107 ARG A 112	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A)	0.36A	6g31E-4p0vA: 13.1	6g31E-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_F_ZOLF401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 5	ASP A 103 ASP A 107 ARG A 112 GLN A 171 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A)	0.69A	6g31F-4p0vA: 26.1	6g31F-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_G_ZOLG401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	6 / 7	ASP A 103 ASP A 107 ARG A 112 GLN A 171 LYS A 200 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A)	0.60A	6g31G-4p0vA: 25.4	6g31G-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_H_ZOLH401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	4 / 5	ASP A 103 ASP A 107 GLN A 171 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A)	0.47A	6g31H-4p0vA: 25.0	6g31H-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_I_ZOLI401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	4 / 4	ASP A 103 ASP A 107 LYS A 200 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 (-2.7A) ZOL A 401 (-3.5A)	1.00A	6g31I-4p0vA: 25.3	6g31I-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_J_ZOLJ401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 6	LEU A 100 ASP A 103 ASP A 107 ARG A 112 GLN A 171	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A)	0.86A	6g31J-4p0vA: 26.4	6g31J-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_J_ZOLJ401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 6	LEU A 100 ASP A 103 ASP A 107 GLN A 171 GLN A 240	None MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A)	0.50A	6g31J-4p0vA: 26.4	6g31J-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_K_ZOLK401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	4 / 4	ASP A 103 ASP A 107 ARG A 112 GLN A 171	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A)	0.43A	6g31K-4p0vA: 24.5	6g31K-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_L_ZOLL401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 6	ASP A 103 ASP A 107 ARG A 112 GLN A 171 GLN A 240	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 2.7A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A)	0.87A	6g31L-4p0vA: 25.9	6g31L-4p0vA: 15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_L_ZOLL401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	4p0v	FARNESYL PYROPHOSPHATE SYNTHASE (Homo sapiens)	5 / 6	ASP A 103 ASP A 107 GLN A 171 GLN A 240 LYS A 266	MG A 405 (-2.5A) MG A 405 (-2.4A) ZOL A 401 ( 3.8A) ZOL A 401 (-3.5A) MG A 405 ( 4.4A)	1.15A	6g31L-4p0vA: 25.9	6g31L-4p0vA: 15.75

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1RQJ_A_RISA901_1","GERANYLTRANSTRANSFERASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.33A","1rqjA-4p0vA:31.1",null],["1RQJ_B_RISB903_1","GERANYLTRANSTRANSFERASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.34A","1rqjB-4p0vA:31.2","1rqjA-4p0vA:27.90"],["1YHL_A_RISA1400_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.30A","1yhlA-4p0vA:45.8","1rqjB-4p0vA:27.90"],["1YQ7_A_RISA901_1","FARNESYL PYROPHOSPHATE SYNTHETASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.34A","1yq7A-4p0vA:53.1","1yhlA-4p0vA:37.97"],["1YV5_A_RISA901_1","FARNESYL PYROPHOSPHATE SYNTHETASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 107;ARG A 112;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","1.20A","1yv5A-4p0vA:53.5","1yq7A-4p0vA:100.00"],["1YV5_A_RISA901_1","FARNESYL PYROPHOSPHATE SYNTHETASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.18A","1yv5A-4p0vA:53.5","1yv5A-4p0vA:100.00"],["1ZW5_A_ZOLA901_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.27A","1zw5A-4p0vA:54.8","1yv5A-4p0vA:100.00"],["2E91_A_ZOLA901_1","GERANYLGERANYL PYROPHOSPHATE SYNTHETASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",8,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A)","0.41A","2e91A-4p0vA:25.3","1zw5A-4p0vA:100.00"],["2E91_B_ZOLB902_1","GERANYLGERANYL PYROPHOSPHATE SYNTHETASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",8,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A)","0.56A","2e91B-4p0vA:24.4","2e91A-4p0vA:24.73"],["2F89_F_210F9001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.27A","2f89F-4p0vA:56.6","2e91B-4p0vA:24.73"],["2F8C_F_ZOLF9001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.13A","2f8cF-4p0vA:56.3","2f89F-4p0vA:100.00"],["2F8Z_F_ZOLF5001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 107;ARG A 112;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","1.16A","2f8zF-4p0vA:56.6","2f8cF-4p0vA:100.00"],["2F8Z_F_ZOLF5001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.29A","2f8zF-4p0vA:56.6","2f8zF-4p0vA:100.00"],["2F94_F_BFQF9001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.56A","2f94F-4p0vA:55.2","2f8zF-4p0vA:100.00"],["2F94_F_BFQF9001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.27A","2f94F-4p0vA:55.2","2f94F-4p0vA:100.00"],["2F9K_F_ZOLF9001_1","FARNESYL DIPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.18A","2f9kF-4p0vA:55.3","2f94F-4p0vA:100.00"],["2O1O_A_RISA400_1","PUTATIVE FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",8,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A)","0.40A","2o1oA-4p0vA:36.3","2f9kF-4p0vA:100.00"],["2O1O_B_RISB400_1","PUTATIVE FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",8,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A)","0.43A","2o1oB-4p0vA:37.0","2o1oA-4p0vA:29.40"],["2O1O_B_RISB400_1","PUTATIVE FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"LEU A 100;ASP A 103;ASP A 107;GLN A 171;LYS A 200;LYS A 266","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A); MG A 405 ( 4.4A)","1.20A","2o1oB-4p0vA:37.0","2o1oB-4p0vA:29.40"],["2Q58_A_ZOLA1_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"LEU A 100;ASP A 103;ARG A 112;GLN A 171;LYS A 200;ASP A 261","None; MG A 405 (-2.5A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A); MG A 404 ( 3.7A)","1.35A","2q58A-4p0vA:36.2","2o1oB-4p0vA:29.40"],["2Q58_A_ZOLA1_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 244","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A);None","0.60A","2q58A-4p0vA:36.2","2q58A-4p0vA:29.40"],["2Q58_B_ZOLB2_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",7,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A)","0.42A","2q58B-4p0vA:36.3","2q58A-4p0vA:29.40"],["2Q58_B_ZOLB2_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;GLN A 171;LYS A 200;LYS A 266"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A); MG A 405 ( 4.4A)","1.38A","2q58B-4p0vA:36.3","2q58B-4p0vA:29.40"],["2QIS_A_RISA901_1","FARNESYL PYROPHOSPHATE SYNTHETASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.23A","2qisA-4p0vA:54.7","2q58B-4p0vA:29.40"],["3EZ3_A_ZOLA397_1","FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.48A","3ez3A-4p0vA:45.5","2qisA-4p0vA:99.71"],["3EZ3_B_ZOLB397_1","FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.32A","3ez3B-4p0vA:44.7","3ez3A-4p0vA:32.83"],["3EZ3_C_ZOLC397_1","FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.46A","3ez3C-4p0vA:45.4","3ez3B-4p0vA:32.83"],["3EZ3_D_ZOLD397_1","FARNESYL PYROPHOSPHATE SYNTHASE, PUTATIVE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.30A","3ez3D-4p0vA:44.3","3ez3C-4p0vA:32.83"],["3IBA_A_ZOLA901_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.45A","3ibaA-4p0vA:45.6","3ez3D-4p0vA:32.83"],["3LDW_A_ZOLA397_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.48A","3ldwA-4p0vA:45.4","3ibaA-4p0vA:37.97"],["3LDW_B_ZOLB397_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.32A","3ldwB-4p0vA:44.6","3ldwA-4p0vA:32.83"],["3LDW_C_ZOLC397_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.45A","3ldwC-4p0vA:45.3","3ldwB-4p0vA:32.83"],["3LDW_D_ZOLD397_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.31A","3ldwD-4p0vA:44.3","3ldwC-4p0vA:32.83"],["3N45_F_ZOLF354_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.19A","3n45F-4p0vA:54.9","3ldwD-4p0vA:32.83"],["3N46_F_ZOLF354_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.25A","3n46F-4p0vA:54.3","3n45F-4p0vA:100.00"],["4KFA_A_ZOLA404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.30A","4kfaA-4p0vA:53.4","3n46F-4p0vA:100.00"],["4KPD_A_RISA405_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.21A","4kpdA-4p0vA:55.9","4kfaA-4p0vA:99.71"],["4KPJ_A_210A901_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.26A","4kpjA-4p0vA:53.7","4kpdA-4p0vA:99.71"],["4KQ5_A_ZOLA404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.31A","4kq5A-4p0vA:54.2","4kpjA-4p0vA:99.71"],["4KQS_A_RISA405_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.22A","4kqsA-4p0vA:54.8","4kq5A-4p0vA:99.71"],["4N9U_A_RISA404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;GLN A 171;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 ( 3.8A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.29A","4n9uA-4p0vA:54.2","4kqsA-4p0vA:99.71"],["4NG6_A_RISA405_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;GLN A 171;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 ( 3.8A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.53A","4ng6A-4p0vA:55.0","4n9uA-4p0vA:99.42"],["4NG6_A_RISA405_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.33A","4ng6A-4p0vA:55.0","4ng6A-4p0vA:99.71"],["4NKE_A_RISA404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.38A","4nkeA-4p0vA:53.7","4ng6A-4p0vA:99.71"],["4NKF_A_210A404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.30A","4nkfA-4p0vA:54.6","4nkeA-4p0vA:99.42"],["4NUA_A_RISA901_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.44A","4nuaA-4p0vA:54.5","4nkfA-4p0vA:99.42"],["4OGU_A_210A405_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",9,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.21A","4oguA-4p0vA:54.2","4nuaA-4p0vA:99.14"],["4P0W_A_ZOLA501_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",11,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.14A","4p0wA-4p0vA:57.2","4oguA-4p0vA:99.42"],["4Q23_A_RISA901_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.21A","4q23A-4p0vA:53.7","4p0wA-4p0vA:100.00"],["4RXD_A_RISA1404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.26A","4rxdA-4p0vA:44.9","4q23A-4p0vA:99.71"],["4RXD_B_RISB1504_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.25A","4rxdB-4p0vA:45.3","4rxdA-4p0vA:37.20"],["4RXD_C_RISC1600_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",10,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.26A","4rxdC-4p0vA:45.2","4rxdB-4p0vA:37.20"],["4UMJ_A_BFQA1297_1","GERANYLTRANSTRANSFERASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A)","0.68A","4umjA-4p0vA:23.8","4rxdC-4p0vA:37.20"],["4UMJ_B_BFQB1294_1","GERANYLTRANSTRANSFERASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",7,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;THR A 201","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A)","0.59A","4umjB-4p0vA:23.8","4umjA-4p0vA:28.41"],["4UMJ_B_BFQB1294_1","GERANYLTRANSTRANSFERASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None","1.24A","4umjB-4p0vA:23.8","4umjB-4p0vA:28.41"],["5CG5_A_RISA400_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",12,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;GLN A 171;LYS A 200;THR A 201;TYR A 204;GLN A 240;ASP A 243;LYS A 257","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);None;ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.23A","5cg5A-4p0vA:53.8","4umjB-4p0vA:28.41"],["5CG6_A_RISA404_1","FARNESYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",12,"PHE A  99;LEU A 100;ASP A 103;ASP A 107;ARG A 112;THR A 167;GLN A 171;LYS A 200;THR A 201;GLN A 240;ASP A 243;LYS A 257","None;None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);None;ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);1WO A 402 ( 2.8A)","0.23A","5cg6A-4p0vA:54.7","5cg5A-4p0vA:99.71"],["5ERO_A_210A804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"LEU A 100;ASP A 103;ARG A 112;LYS A 200;LYS A 257","None; MG A 405 (-2.5A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);1WO A 402 ( 2.8A)","1.36A","5eroA-4p0vA:27.5","5cg6A-4p0vA:99.71"],["5ERO_A_210A804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",7,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;LYS A 200;GLN A 240;ASP A 243","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A)","0.62A","5eroA-4p0vA:27.5","5eroA-4p0vA:23.44"],["5ERO_B_210B804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ARG A 112;LYS A 200;ASP A 244;LYS A 257"," MG A 405 (-2.5A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);None;1WO A 402 ( 2.8A)","1.30A","5eroB-4p0vA:27.1","5eroA-4p0vA:23.44"],["5ERO_B_210B804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",7,"ASP A 103;ASP A 107;ARG A 112;LYS A 200;GLN A 240;ASP A 243;ASP A 244"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);None","0.53A","5eroB-4p0vA:27.1","5eroB-4p0vA:23.44"],["5ERO_B_210B804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;LYS A 200;GLN A 240;ASP A 243"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A)","1.42A","5eroB-4p0vA:27.1","5eroB-4p0vA:23.44"],["5ERO_B_210B804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 107;ARG A 112;GLN A 240;ASP A 243;ASP A 244"," MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);None","1.34A","5eroB-4p0vA:27.1","5eroB-4p0vA:23.44"],["5ERO_C_210C804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",8,"ASP A 103;ASP A 104;ASP A 107;ARG A 112;LYS A 200;GLN A 240;ASP A 243;ASP A 244"," MG A 405 (-2.5A);None; MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);None","0.58A","5eroC-4p0vA:27.3","5eroB-4p0vA:23.44"],["5ERO_C_210C804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",7,"ASP A 103;ASP A 107;ARG A 112;LYS A 200;GLN A 240;ASP A 244;LYS A 257"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A);None;1WO A 402 ( 2.8A)","0.98A","5eroC-4p0vA:27.3","5eroC-4p0vA:23.44"],["5ERO_C_210C804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;LYS A 200;GLN A 240;ASP A 243"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A)","1.39A","5eroC-4p0vA:27.3","5eroC-4p0vA:23.44"],["5ERO_C_210C804_1","FUSICOCCADIENE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"ASP A 107;ASP A 104;ARG A 112;GLN A 240;ASP A 243;ASP A 244"," MG A 405 (-2.4A);None;ZOL A 401 ( 2.7A);ZOL A 401 (-3.5A); MG A 404 (-2.8A);None","1.37A","5eroC-4p0vA:27.3","5eroC-4p0vA:23.44"],["6G31_A_ZOLA401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A)","1.07A","6g31A-4p0vA:26.2","5eroC-4p0vA:23.44"],["6G31_B_ZOLB401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A)","0.73A","6g31B-4p0vA:26.2","6g31A-4p0vA:15.75"],["6G31_C_ZOLC401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A)","1.21A","6g31C-4p0vA:26.5","6g31B-4p0vA:15.75"],["6G31_D_ZOLD401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171;GLN A 240","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A)","0.54A","6g31D-4p0vA:25.4","6g31C-4p0vA:15.75"],["6G31_E_ZOLE401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",4,"LEU A 100;ASP A 103;ASP A 107;ARG A 112","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A)","0.36A","6g31E-4p0vA:13.1","6g31D-4p0vA:15.75"],["6G31_F_ZOLF401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A)","0.69A","6g31F-4p0vA:26.1","6g31E-4p0vA:15.75"],["6G31_G_ZOLG401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",6,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;LYS A 200;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A)","0.60A","6g31G-4p0vA:25.4","6g31F-4p0vA:15.75"],["6G31_H_ZOLH401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",4,"ASP A 103;ASP A 107;GLN A 171;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A)","0.47A","6g31H-4p0vA:25.0","6g31G-4p0vA:15.75"],["6G31_I_ZOLI401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",4,"ASP A 103;ASP A 107;LYS A 200;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 (-2.7A);ZOL A 401 (-3.5A)","1.00A","6g31I-4p0vA:25.3","6g31H-4p0vA:15.75"],["6G31_J_ZOLJ401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"LEU A 100;ASP A 103;ASP A 107;ARG A 112;GLN A 171","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A)","0.86A","6g31J-4p0vA:26.4","6g31I-4p0vA:15.75"],["6G31_J_ZOLJ401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"LEU A 100;ASP A 103;ASP A 107;GLN A 171;GLN A 240","None; MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A)","0.50A","6g31J-4p0vA:26.4","6g31J-4p0vA:15.75"],["6G31_K_ZOLK401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",4,"ASP A 103;ASP A 107;ARG A 112;GLN A 171"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A)","0.43A","6g31K-4p0vA:24.5","6g31J-4p0vA:15.75"],["6G31_L_ZOLL401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;ARG A 112;GLN A 171;GLN A 240"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 2.7A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A)","0.87A","6g31L-4p0vA:25.9","6g31K-4p0vA:15.75"],["6G31_L_ZOLL401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","4p0v","FARNESYL PYROPHOSPHATE SYNTHASE","Homo sapiens",5,"ASP A 103;ASP A 107;GLN A 171;GLN A 240;LYS A 266"," MG A 405 (-2.5A); MG A 405 (-2.4A);ZOL A 401 ( 3.8A);ZOL A 401 (-3.5A); MG A 405 ( 4.4A)","1.15A","6g31L-4p0vA:25.9","6g31L-4p0vA:15.75"]]